| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697901 | Clinical Oncology | 2016 | 11 Pages |
Abstract
PBT is an excellent modality to treat uveal melanomas, with high survival outcomes and visual acuity preservation. Although there are low toxicity and enucleation rates, the recent development of supportive therapies for radiation toxicities can further decrease clinical adverse effects.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
V. Verma, M.P. Mehta,